QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 210 filers reported holding QIAGEN NV in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,761,000 | +32.5% | 173,500 | +5.4% | 0.01% | +18.2% |
| Q2 2016 | $3,592,000 | +8.5% | 164,677 | +11.1% | 0.01% | +10.0% |
| Q1 2016 | $3,310,000 | -21.7% | 148,176 | -3.0% | 0.01% | -28.6% |
| Q4 2015 | $4,225,000 | +8.2% | 152,792 | +1.0% | 0.01% | +7.7% |
| Q3 2015 | $3,904,000 | +11.0% | 151,310 | +6.7% | 0.01% | +18.2% |
| Q2 2015 | $3,517,000 | -9.9% | 141,858 | -8.4% | 0.01% | 0.0% |
| Q1 2015 | $3,904,000 | +8.3% | 154,917 | +0.8% | 0.01% | +10.0% |
| Q4 2014 | $3,605,000 | +7.6% | 153,646 | +4.4% | 0.01% | 0.0% |
| Q3 2014 | $3,350,000 | -6.8% | 147,126 | +0.0% | 0.01% | -9.1% |
| Q2 2014 | $3,596,000 | +21.7% | 147,056 | +5.0% | 0.01% | +22.2% |
| Q1 2014 | $2,954,000 | -14.5% | 140,085 | -3.4% | 0.01% | -10.0% |
| Q4 2013 | $3,453,000 | +2.9% | 145,025 | -7.5% | 0.01% | 0.0% |
| Q3 2013 | $3,355,000 | +6.9% | 156,780 | -0.5% | 0.01% | 0.0% |
| Q2 2013 | $3,137,000 | – | 157,580 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exane Asset Management | 642,752 | $14,260,214,000 | 5.53% |
| Tikvah Management LLC | 369,425 | $8,057,000 | 4.72% |
| Hardman Johnston Global Advisors LLC | 3,797,024 | $82,813,000 | 4.22% |
| HealthCor Management, L.P. | 2,500,000 | $54,525,000 | 2.97% |
| Opus Point Partners Management, LLC | 105,751 | $2,306,000 | 2.23% |
| CRAMER ROSENTHAL MCGLYNN LLC | 4,018,074 | $87,634,000 | 1.41% |
| Douglas Lane & Associates, LLC | 1,942,678 | $42,370,000 | 1.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,167,768 | $47,279,000 | 1.17% |
| MANNING & NAPIER ADVISORS LLC | 6,111,364 | $133,287,000 | 0.81% |
| PRIMECAP MANAGEMENT CO/CA/ | 20,128,325 | $438,999,000 | 0.47% |